<p>Acurx Pharmaceuticals Inc. 宣布其股东已批准对公司章程的修订，将普通股的授权总股数从 2 亿股增加至 2.5 亿股。该修订已向特拉华州国务卿提交，并立即生效。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。尽管 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Acurx Pharmaceuticals Inc. 于 2025 年 9 月 22 日通过美国证券交易委员会（Ref. ID: 0001104659-25-092166）运营的电子数据收集、分析和检索系统 EDGAR 发布了用于生成本新闻简报的原始内容，并对此信息的准确性承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里</p>

ACXP

<p>Acurx Pharmaceuticals Inc. 已获得股东批准，修改其公司章程，将授权的普通股总数从 2 亿股增加至 2.5 亿股。该修正案已向特拉华州国务卿提交，并立即生效</p>

<p>Acurx Pharmaceuticals Inc. announced that its stockholders have approved an amendment to the company’s Certificate of Incorporation, increasing the total number of authorized shares of common stock from 200 million to 250 million. The amendment was filed with the Secretary of State of Delaware and took effect immediately. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acurx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-092166), on September 22, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>
<div class="lb-trans"><p>Acurx Pharmaceuticals Inc. 宣布其股东已批准对公司章程的修订，将普通股的授权总股数从 2 亿股增加至 2.5 亿股。该修订已向特拉华州国务卿提交，并立即生效。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。尽管 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Acurx Pharmaceuticals Inc. 于 2025 年 9 月 22 日通过美国证券交易委员会（Ref. ID: 0001104659-25-092166）运营的电子数据收集、分析和检索系统 EDGAR 发布了用于生成本新闻简报的原始内容，并对此信息的准确性承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里</p>
</div>

Acurx Pharmaceuticals 将其授权股份数量增加至 2.5 亿股